We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
2976
Autolus Therapeutics
AUTL
$554M
$63.1K ﹤0.01%
9,793
-7,903
-45% -$30.1K
SUN icon
2977
Sunoco
SUN
$14.3B
$63K ﹤0.01%
1,052
-6,305
-86% -$335K
GDOT icon
2978
Green Dot
GDOT
$770M
$62.9K ﹤0.01%
6,354
-2,651
-29% -$27.6K
CWEN icon
2979
Clearway Energy Class C
CWEN
$7.11B
$62.6K ﹤0.01%
2,281
-5,614
-71% -$131K
TSVT
2980
DELISTED
2seventy bio
TSVT
$62.5K ﹤0.01%
14,629
+1,925
+15% +$5.92K
AGQ icon
2981
ProShares Ultra Silver
AGQ
$1.46B
$62.4K ﹤0.01%
2,298
+1,778
+342% +$47.1K
BCRX icon
2982
BioCryst Pharmaceuticals
BCRX
$2.45B
$62.4K ﹤0.01%
10,420
+5,912
+131% +$34.3K
SGHT icon
2983
Sight Sciences
SGHT
$457M
$62.3K ﹤0.01%
12,076
+7,764
+180% +$24K
SNDR icon
2984
Schneider National
SNDR
$6.41B
$62.2K ﹤0.01%
2,443
-9,747
-80% -$240K
SPUS icon
2985
SP Funds S&P 500 Sharia ETF
SPUS
$3.08B
$62.1K ﹤0.01%
+1,817
New +$58.5K
IWX icon
2986
iShares Russell Top 200 Value ETF
IWX
$4.04B
$62K ﹤0.01%
884
-4,892
-85% -$325K
OM icon
2987
Outset Medical
OM
$82.7M
$61.9K ﹤0.01%
763
-366
-32% -$29.8K
BLUE
2988
DELISTED
bluebird bio
BLUE
$61.9K ﹤0.01%
2,242
+1,169
+109% +$71.3K
HFWA icon
2989
Heritage Financial
HFWA
$1.23B
$61.9K ﹤0.01%
2,892
-10,069
-78% -$183K
ICL icon
2990
ICL Group
ICL
$7.16B
$61.7K ﹤0.01%
12,315
+12,298
+72,341% +$62.6K
IRWD icon
2991
Ironwood Pharmaceuticals
IRWD
$681M
$61.6K ﹤0.01%
5,382
-19,987
-79% -$198K
GEL icon
2992
Genesis Energy
GEL
$1.93B
$61.5K ﹤0.01%
5,311
+3,347
+170% +$38.3K
APAM icon
2993
Artisan Partners
APAM
$2.98B
$61.5K ﹤0.01%
1,391
-757
-35% -$28.6K
PRA
2994
DELISTED
ProAssurance
PRA
$61.4K ﹤0.01%
4,449
+842
+23% +$12.9K
BLNK icon
2995
Blink Charging
BLNK
$87.3M
$61.3K ﹤0.01%
18,074
+13,816
+324% +$43.1K
KODK icon
2996
Kodak
KODK
$975M
$61.2K ﹤0.01%
15,687
+11,130
+244% +$42.8K
ENTA icon
2997
Enanta Pharmaceuticals
ENTA
$384M
$61.2K ﹤0.01%
6,501
+277
+4% +$2.58K
PACK icon
2998
Ranpak Holdings
PACK
$468M
$61.1K ﹤0.01%
10,500
+8,390
+398% +$35.4K
CFLT
2999
DELISTED
Confluent
CFLT
$61.1K ﹤0.01%
2,610
-9,577
-79% -$231K
JEPI icon
3000
JPMorgan Equity Premium Income ETF
JEPI
$46.2B
$60.9K ﹤0.01%
+1,108
New +$59.7K
118 119
120
121 122

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.